Prashant Chittiboina, M.D.

Investigator

Neurosurgery Unit for Pituitary and Inheritable Diseases

NINDS

Building 10, Room 3D20
MSC 1065
10 Center Drive
Bethesda, MD 20814

301-496-2921

prashant.chittiboina@nih.gov

Research Topics

The emphasis of my unit is translational research to address challenging clinical problems . Using precious surgical tissues, my group performs transcriptomic, epigenomic and functional mapping of central nervous system tumors. A detailed map of the transcriptome and epigenome in pituitary and inheritable tumors is generating hypotheses and is improving our understanding of underlying pathogenic mechanisms. We have also successfully applied these findings back to the clinical realm with clinical trials in metabolic imaging and targeted therapy of central nervous system tumors.

Biography

Dr. Chittiboina earned his M.D. from Goa University (India) in 2000 and a Master of Public Health from Idaho State University in 2004. He completed his residency in neurosurgery at Louisiana State University in 2012. During his residency, Dr. Chittiboina also completed a year-long research fellowship studying neuro-vascular disease. He came to NINDS in 2012 as a translational research fellow, becoming a Staff Clinician in the Surgical Neurology Branch in 2013. He became an Assistant Clinical Investigator in 2015 and a Tenure Track Investigator in 2020. His laboratory studies neurosurgical disorders of the pituitary gland and inheritable tumor syndromes. His current work is focused on improving the outcomes of neurosurgical disorders through translational research approaches.

Selected Publications

  1. Asuzu D, Chatain GP, Hayes C, Benzo S, McGlotten R, Keil M, Beri A, Sharma ST, Nieman L, Lodish M, Stratakis C, Lonser RR, Oldfield EH, Chittiboina P. Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease. J Clin Endocrinol Metab. 2017;102(7):2179-2187.

  2. Lu J, Chatain GP, Bugarini A, Wang X, Maric D, Walbridge S, Zhuang Z, Chittiboina P. Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease. J Clin Endocrinol Metab. 2017;102(8):2825-2835.

  3. Chittiboina P, Talagala SL, Merkle H, Sarlls JE, Montgomery BK, Piazza MG, Scott G, Ray-Chaudhury A, Lonser RR, Oldfield EH, Koretsky AP, Butman JA. Endosphenoidal coil for intraoperative magnetic resonance imaging of the pituitary gland during transsphenoidal surgery. J Neurosurg. 2016;125(6):1451-1459.

  4. Boyle J, Patronas NJ, Smirniotopoulos J, Herscovitch P, Dieckman W, Millo C, Maric D, Chatain GP, Hayes CP, Benzo S, Scott G, Edwards N, Ray Chaudhury A, Lodish MB, Sharma S, Nieman LK, Stratakis CA, Lonser RR, Chittiboina P. CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease. Endocrine. 2019;65(1):155-165.

  5. Lu J, Montgomery BK, Chatain GP, Bugarini A, Zhang Q, Wang X, Edwards NA, Ray-Chaudhury A, Merrill MJ, Lonser RR, Chittiboina P. Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1. Mol Cell Endocrinol. 2018;470:105-114.


This page was last updated on April 25th, 2022